Probable Treatment Targets for Diabetic Retinopathy Based on an Integrated Proteomic and Genomic Analysis

CONCLUSIONS: The bioinformatics pipeline described here identifies FDA-approved drugs that can be used for new alternative indications. These theoretical candidate drugs should be validated with experimental studies.TRANSLATIONAL RELEVANCE: Our study suggests possible drugs for DR treatment based on an integrated proteomics and genomics pipeline. This approach can potentially expedite the drug discovery process by identifying already-approved drugs that might be used for new indications.PMID:36745438 | DOI:10.1167/tvst.12.2.8
Source: Genomics Proteomics ... - Category: Genetics & Stem Cells Authors: Source Type: research